Is Catheter Precision, Inc. (VTAK) a Buy, Sell, or Hold?
Catheter Precision, Inc.
AMEX:VTAK
$0.56 USD
-$0.09 (-13.9%)
- Volume
- 23.64M
- Average Volume
- 6.65M
- Market Capitalization
- $605.06K
- P/E Ratio
- -0.08
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $4.94
- Year Low
- $0.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.06
Industry, Sector & symbol
| Stock Exchange | AMEX |
| CEO | David A. Jenkins |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Current Symbol | VTAK |
| CUSIP | 74933X708 |
| CIK | 0001716621 |
| Web | https://www.catheterprecision.com |
| Phone | 973 691 2000 |
| Currency | USD |
| Employees | 17 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 1.25 |
| Payout Ratio | 0.00 |
| Current Ratio | 0.06 |
| Quick Ratio | 0.06 |
| Cash Ratio | 0.02 |
Sales & Book Value
| Annual Sales | $819K |
| Price / Sales | 0.55 |
| Cash Flow | 0.00 |
| Price / Cash Flow | -0.07 |
| Price / Book | 128.27 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Strong Sell |
| Rating Score(0-5) | 1 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-15.9 |
| Trailing P/E Ratio | -0.08 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | $-17.18M |
| Net Margin | -1338.27% |
| Pretax Margin | -1498.29% |
| Return on Equity | -196.44% |
| Return on Assets | -42.26% |
Financials Score
| AltmanZ Score | -14.55 |
| Piotroski Score | 3.00 |
| Working Capital | -18.49M |
| Total Assets | 35.08M |
| Ebit | -16.49M |
| Market Cap | 702.74K |
| Total Liabilities | 25.93M |
Poll Results
About Catheter Precision, Inc. (AMEX:VTAK) Stock
Catheter Precision, Inc., headquartered in Fort Mill, South Carolina, is dedicated to creating and distributing electrophysiology products. Their mission is to enhance treatment and outcomes for U.S. patients suffering from cardiac arrhythmias by providing innovative technologies and solutions to patients, hospitals, and physicians. Their premier product, the View into Ventricular Onset System (VIVO), is a non-invasive 3D cardiac mapping solution designed to accurately locate the origin points of idiopathic ventricular arrhythmias in patients with otherwise healthy hearts, before they undergo electrophysiology procedures. Additionally, they offer LockeT, a device for suture retention, and the Amigo Remote Catheter System, a robotic arm used for precise catheter control. The company, previo ... usly known as Ra Medical Systems, Inc., officially adopted the name Catheter Precision, Inc. in August 2023.
Flyte Partners with LifeVac to Equip Every Vision Jet with Life-Saving Equipment
2026-07-07 16:15:00
Every FLYTE aircraft combines the Cirrus Vision Jet's CAPS whole-aircraft parachute and Safe Return Emergency Autoland with onboard LifeVac life-saving equipment .
Flyte Announces Successful Launch of New Direct-to-Consumer Booking Platform
2026-07-02 08:00:00
Revenue Increased Sequentially Approximately 170% from Q1 to Q2 (QoQ) as Customer Adoption Accelerates Across Key Travel Markets Revenue Increased Sequentially Approximately 170% from Q1 to Q2 (QoQ) as Customer Adoption Accelerates Across Key Travel Markets
FLYTE EXPANDS STRATEGIC RELATIONSHIP WITH VOLATO BY JOINING VAUNT PLATFORM
2026-06-11 08:00:00
Flyte Gains Access to Fast-Growing Private Aviation Membership Network While Unlocking New Revenue Opportunities across Its Cirrus Vision Jet Fleet Creates Additional Distribution Channel for Flyte and Enhances Empty Leg Inventory Available to Vaunt Members FORT MILL, S.C., June 11, 2026 (GLOBE NEWSWIRE) -- Fly Flyte, Inc. ("Flyte"), the rapidly growing Regional Air Mobility subsidiary of Catheter Precision, Inc. (NYSE American: VTAK), today announced that it has joined the Vaunt operator network, a membership-based private aviation platform owned by Volato Group, Inc. (NYSE American: SOAR).
Flyte (VTAK) Makes Strategic Investment in Volato (SOAR)
2026-06-08 10:43:00
VTAK Becomes Volato's Largest Shareholder through Acquisition of a 7.5% Ownership Stake Investment Supports Potential Collaboration across Aviation Platforms and Accelerates Growth Opportunities across Both Companies VTAK Becomes Volato's Largest Shareholder through Acquisition of a 7.5% Ownership Stake Investment Supports Potential Collaboration across Aviation Platforms and Accelerates Growth Opportunities across Both Companies
Volato Group Announces $2.2 Million Strategic Investment and AI Infrastructure Acquisition Focus
2026-06-08 06:15:00
ATLANTA--(BUSINESS WIRE)--Volato Group, Inc. (NYSE American: SOAR) (the “Company” or “Volato”), a technology company focused on building scalable software and data solutions that improve the reliability and intelligence of high-stakes business decisions, today announced the signing of a definitive agreement to obtain a $2.2 million strategic investment lead by Catheter Precision, Inc. (NYSE American: VTAK), and other institutional investors with experience investing in artificial intelligence a.
2026-05-21 08:00:00
Company Deploys Scalable Short-Haul Model into Peak Travel Window as Millions Exit NYC Metro Flagship Routes to Nantucket, Hamptons, and Martha's Vineyard Positioned for Immediate Revenue Acceleration and High Utilization FORT MILL, S.C., May 21, 2026 (GLOBE NEWSWIRE) -- Flyte, a regional air mobility company focused on making private aviation more accessible and flexible for modern travelers, today announced the full-scale activation of its Memorial Day flight network, aggressively deploying aircraft across its Northeast corridor to capitalize on one of the largest and most predictable travel surges of the year.
2026-05-12 08:00:00
Company Deploys Scalable Short-Haul Model Following Kentucky Derby to Monetize Peak Travel Window Flagship Routes from NYC, Boston, DC, and Philadelphia Positioned to Drive Immediate Revenue, High Utilization, and Dense Flight Activity NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”), today announced the positioning of aircraft across the Northeast to support increased travel demand this coming weekend in anticipation of the Preakness Stakes on Saturday, May 16th. The program centers on Baltimore/Washington International Airport (BWI), the primary access point for race attendees, with high-frequency short-haul service from major Northeast metros.
2026-05-04 10:30:00
Premium Short-Haul Operator Continues Planned Vision Jet Fleet Expansion and Opens Hiring Pipeline for Impacted Pilots and Aviation Professionals Premium Short-Haul Operator Continues Planned Vision Jet Fleet Expansion and Opens Hiring Pipeline for Impacted Pilots and Aviation Professionals
Frequently Asked Questions
-
What is the current Catheter Precision, Inc. (VTAK) stock price?
-
Catheter Precision, Inc.(AMEX:VTAK) stock price is $0.56 in the last trading session. During the trading session, VTAK stock reached the peak price of $4.94 while $0.55 was the lowest point it dropped to. The percentage change in VTAK stock occurred in the recent session was --13.9% while the dollar amount for the price change in VTAK stock was -$-0.09.
-
VTAK's industry and sector of operation?
-
The AMEX listed VTAK is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of VTAK?
-
Philip Anderson | Chief Financial Officer & Secretary
David A. Jenkins | Chief Executive Officer, Chief Commercial Officer & Executive Chairman
|
|
| -
How many employees does VTAK have?
-
Number of VTAK employees currently stands at 17. VTAK operates from 1670 Highway 160 West, Fort Mill, SC 29708, US.
-
Link for VTAK official website?
-
Official Website of VTAK is: https://www.catheterprecision.com
-
How do I contact VTAK?
-
VTAK could be contacted at phone #973 691 2000 and can also be accessed through its website. VTAK operates from 1670 Highway 160 West, Fort Mill, SC 29708, US.
-
How many shares of VTAK are traded daily?
-
The average number of VTAK shares traded daily for last 3 months was 6.65M.
-
What is the market cap of VTAK currently?
-
The market value of VTAK currently stands at $605.06K with its latest stock price at $0.56